AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2004 OCT 7 - (NewsRx.com & NewsRx.net) -- Study findings support the use of kanamycin for treatment of aerobic vaginitis.
"The term 'aerobic vaginitis' defines a 'new' vaginal pathology that is neither classifiable as specific vaginitis nor as bacterial vaginosis," said G. Tempera and colleagues, University of Catania, Italy.
They compared efficacy and tolerability of kanamycin and meclocycline for treatment of clinically and microbiologically verified aerobic vaginitis in 30 women. Kanamycin and meclocycline are commercially available in Italy in the form of vaginal pessaries.
"In chronological order of enrollment, the patients were alternately treated with kanamycin or meclocycline; the dose of administration in both groups was of one pessary per day for 6 days," the researchers explained. "The evaluation of the therapeutic efficacy was carried out both at the first check-up (7th-8th day) and at a second check-up (13th-16th day)."
Tempera and associates reported, "At the first follow-up carried out immediately at the end of therapy, the percentage of normalization of clinical signs and symptoms was increased independently of the type of treatment in the case of moderate grade aerobic vaginitis, while kanamycin was produced a better effect in the group with ...
Source: HighBeam Research, Study validates kanamycin therapy for recently described aerobic...